Senti Bio has agreed to sublease its recently opened Alameda, California facility to newly created CDMO GeneFab.  During its Q2 results, cell and gene therapy developer Senti Bio confirmed the sublease of the recently opened facility to GeneFab – a newly formed contract development and manufacturing organization (CDMO) backed by private equity firm Celadon Partners. The agreement will bring Senti Bio additional capital and reduced longer-term operating expenses, extending the company’s cash runway into the fourth quarter of 2024. The…